The global Cell And Gene Therapy Clinical Trial market was valued at US$ 9 million in 2022 and is projected to reach US$ 37 million by 2029, at a CAGR of 21.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The next generation of cell and gene therapies holds a significant promise for patients as an alternative treatment option or personalized medicine. Besides, the success rate of these products is also higher as compared to those for small-molecule products. This is due to the fact that CGT tends to target precise disease drivers rather than the broad targets for small-molecule therapy.
This report aims to provide a comprehensive presentation of the global market for Cell And Gene Therapy Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell And Gene Therapy Clinical Trial. This report contains market size and forecasts of Cell And Gene Therapy Clinical Trial in global, including the following market information:
- Global Cell And Gene Therapy Clinical Trial Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Phase I Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell And Gene Therapy Clinical Trial include IQVIA, ICON Plc, Covance, Charles River Laboratory and PAREXEL International Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell And Gene Therapy Clinical Trial companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell And Gene Therapy Clinical Trial Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Cell And Gene Therapy Clinical Trial Market Segment Percentages, by Type, 2022 (%)
- Phase I
- Phase II
- Phase III
- Phase IV
Global Cell And Gene Therapy Clinical Trial Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Cell And Gene Therapy Clinical Trial Market Segment Percentages, by Application, 2022 (%)
- Oncology
- Cardiology
- CNS
- Musculoskeletal
- Infectious Diseases
- Dermatology
- Endocrine, Metabolic, Genetic
- Immunology & Inflammation
- Ophthalmology
- Others(Gastroenterology, Hematology,etc.)
Global Cell And Gene Therapy Clinical Trial Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Cell And Gene Therapy Clinical Trial Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell And Gene Therapy Clinical Trial revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell And Gene Therapy Clinical Trial revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- IQVIA
- ICON Plc
- Covance
- Charles River Laboratory
- PAREXEL International Corporation
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Cell And Gene Therapy Clinical Trial, market overview.
- Chapter 2: Global Cell And Gene Therapy Clinical Trial market size in revenue.
- Chapter 3: Detailed analysis of Cell And Gene Therapy Clinical Trial company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Cell And Gene Therapy Clinical Trial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell And Gene Therapy Clinical Trial Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell And Gene Therapy Clinical Trial Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell And Gene Therapy Clinical Trial Overall Market Size
2.1 Global Cell And Gene Therapy Clinical Trial Market Size: 2022 VS 2032
2.2 Global Cell And Gene Therapy Clinical Trial Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell And Gene Therapy Clinical Trial Players in Global Market
3.2 Top Global Cell And Gene Therapy Clinical Trial Companies Ranked by Revenue
3.3 Global Cell And Gene Therapy Clinical Trial Revenue by Companies
3.4 Top 3 and Top 5 Cell And Gene Therapy Clinical Trial Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell And Gene Therapy Clinical Trial Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell And Gene Therapy Clinical Trial Players in Global Market
3.6.1 List of Global Tier 1 Cell And Gene Therapy Clinical Trial Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell And Gene Therapy Clinical Trial Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell And Gene Therapy Clinical Trial Market Size Markets, 2022 & 2032
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.1.5 Phase IV
4.2 By Type - Global Cell And Gene Therapy Clinical Trial Revenue & Forecasts
4.2.1 By Type - Global Cell And Gene Therapy Clinical Trial Revenue, 2018-2023
4.2.2 By Type - Global Cell And Gene Therapy Clinical Trial Revenue, 2024-2032
4.2.3 By Type - Global Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell And Gene Therapy Clinical Trial Market Size, 2022 & 2032
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 CNS
5.1.5 Musculoskeletal
5.1.6 Infectious Diseases
5.1.7 Dermatology
5.1.8 Endocrine, Metabolic, Genetic
5.1.9 Immunology & Inflammation
5.1.10 Ophthalmology
5.1.11 Others(Gastroenterology, Hematology,etc.)
5.2 By Application - Global Cell And Gene Therapy Clinical Trial Revenue & Forecasts
5.2.1 By Application - Global Cell And Gene Therapy Clinical Trial Revenue, 2018-2023
5.2.2 By Application - Global Cell And Gene Therapy Clinical Trial Revenue, 2024-2032
5.2.3 By Application - Global Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cell And Gene Therapy Clinical Trial Market Size, 2022 & 2032
6.2 By Region - Global Cell And Gene Therapy Clinical Trial Revenue & Forecasts
6.2.1 By Region - Global Cell And Gene Therapy Clinical Trial Revenue, 2018-2023
6.2.2 By Region - Global Cell And Gene Therapy Clinical Trial Revenue, 2024-2032
6.2.3 By Region - Global Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cell And Gene Therapy Clinical Trial Revenue, 2018-2032
6.3.2 US Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.3.3 Canada Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.3.4 Mexico Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cell And Gene Therapy Clinical Trial Revenue, 2018-2032
6.4.2 Germany Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.4.3 France Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.4.4 U.K. Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.4.5 Italy Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.4.6 Russia Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.4.7 Nordic Countries Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.4.8 Benelux Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cell And Gene Therapy Clinical Trial Revenue, 2018-2032
6.5.2 China Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.5.3 Japan Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.5.4 South Korea Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.5.5 Southeast Asia Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.5.6 India Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cell And Gene Therapy Clinical Trial Revenue, 2018-2032
6.6.2 Brazil Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.6.3 Argentina Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell And Gene Therapy Clinical Trial Revenue, 2018-2032
6.7.2 Turkey Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.7.3 Israel Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.7.4 Saudi Arabia Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
6.7.5 UAE Cell And Gene Therapy Clinical Trial Market Size, 2018-2032
7 Cell And Gene Therapy Clinical Trial Companies Profiles
7.1 IQVIA
7.1.1 IQVIA Company Summary
7.1.2 IQVIA Business Overview
7.1.3 IQVIA Cell And Gene Therapy Clinical Trial Major Product Offerings
7.1.4 IQVIA Cell And Gene Therapy Clinical Trial Revenue in Global Market (2018-2023)
7.1.5 IQVIA Key News & Latest Developments
7.2 ICON Plc
7.2.1 ICON Plc Company Summary
7.2.2 ICON Plc Business Overview
7.2.3 ICON Plc Cell And Gene Therapy Clinical Trial Major Product Offerings
7.2.4 ICON Plc Cell And Gene Therapy Clinical Trial Revenue in Global Market (2018-2023)
7.2.5 ICON Plc Key News & Latest Developments
7.3 Covance
7.3.1 Covance Company Summary
7.3.2 Covance Business Overview
7.3.3 Covance Cell And Gene Therapy Clinical Trial Major Product Offerings
7.3.4 Covance Cell And Gene Therapy Clinical Trial Revenue in Global Market (2018-2023)
7.3.5 Covance Key News & Latest Developments
7.4 Charles River Laboratory
7.4.1 Charles River Laboratory Company Summary
7.4.2 Charles River Laboratory Business Overview
7.4.3 Charles River Laboratory Cell And Gene Therapy Clinical Trial Major Product Offerings
7.4.4 Charles River Laboratory Cell And Gene Therapy Clinical Trial Revenue in Global Market (2018-2023)
7.4.5 Charles River Laboratory Key News & Latest Developments
7.5 PAREXEL International Corporation
7.5.1 PAREXEL International Corporation Company Summary
7.5.2 PAREXEL International Corporation Business Overview
7.5.3 PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Major Product Offerings
7.5.4 PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Revenue in Global Market (2018-2023)
7.5.5 PAREXEL International Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell And Gene Therapy Clinical Trial Market Opportunities & Trends in Global Market
Table 2. Cell And Gene Therapy Clinical Trial Market Drivers in Global Market
Table 3. Cell And Gene Therapy Clinical Trial Market Restraints in Global Market
Table 4. Key Players of Cell And Gene Therapy Clinical Trial in Global Market
Table 5. Top Cell And Gene Therapy Clinical Trial Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell And Gene Therapy Clinical Trial Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell And Gene Therapy Clinical Trial Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell And Gene Therapy Clinical Trial Product Type
Table 9. List of Global Tier 1 Cell And Gene Therapy Clinical Trial Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell And Gene Therapy Clinical Trial Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Cell And Gene Therapy Clinical Trial Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell And Gene Therapy Clinical Trial Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Cell And Gene Therapy Clinical Trial Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell And Gene Therapy Clinical Trial Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Cell And Gene Therapy Clinical Trial Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell And Gene Therapy Clinical Trial Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2024-2032
Table 30. IQVIA Company Summary
Table 31. IQVIA Cell And Gene Therapy Clinical Trial Product Offerings
Table 32. IQVIA Cell And Gene Therapy Clinical Trial Revenue (US$, Mn) & (2018-2023)
Table 33. IQVIA Key News & Latest Developments
Table 34. ICON Plc Company Summary
Table 35. ICON Plc Cell And Gene Therapy Clinical Trial Product Offerings
Table 36. ICON Plc Cell And Gene Therapy Clinical Trial Revenue (US$, Mn) & (2018-2023)
Table 37. ICON Plc Key News & Latest Developments
Table 38. Covance Company Summary
Table 39. Covance Cell And Gene Therapy Clinical Trial Product Offerings
Table 40. Covance Cell And Gene Therapy Clinical Trial Revenue (US$, Mn) & (2018-2023)
Table 41. Covance Key News & Latest Developments
Table 42. Charles River Laboratory Company Summary
Table 43. Charles River Laboratory Cell And Gene Therapy Clinical Trial Product Offerings
Table 44. Charles River Laboratory Cell And Gene Therapy Clinical Trial Revenue (US$, Mn) & (2018-2023)
Table 45. Charles River Laboratory Key News & Latest Developments
Table 46. PAREXEL International Corporation Company Summary
Table 47. PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Product Offerings
Table 48. PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Revenue (US$, Mn) & (2018-2023)
Table 49. PAREXEL International Corporation Key News & Latest Developments
List of Figures
Figure 1. Cell And Gene Therapy Clinical Trial Segment by Type in 2022
Figure 2. Cell And Gene Therapy Clinical Trial Segment by Application in 2022
Figure 3. Global Cell And Gene Therapy Clinical Trial Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell And Gene Therapy Clinical Trial Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Cell And Gene Therapy Clinical Trial Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell And Gene Therapy Clinical Trial Revenue in 2022
Figure 8. By Type - Global Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 9. By Application - Global Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 10. By Type - Global Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 12. By Application - Global Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 14. By Region - Global Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 15. By Country - North America Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 16. US Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 20. Germany Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 21. France Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 28. China Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 32. India Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 34. Brazil Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Cell And Gene Therapy Clinical Trial Revenue Market Share, 2018-2032
Figure 37. Turkey Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Cell And Gene Therapy Clinical Trial Revenue, (US$, Mn), 2018-2032
Figure 41. IQVIA Cell And Gene Therapy Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. ICON Plc Cell And Gene Therapy Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Covance Cell And Gene Therapy Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Charles River Laboratory Cell And Gene Therapy Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
